California Gov. Gavin Newsom on October 11 vetoed the bill that aimed at expanding patient access to medicinal cannabis in America’s oldest legally-regulated marketplace.
This legislation is a good example. Assembly Bill 1332Under certain conditions, a licensed microbusiness could ship medical marijuana directly to California patients using common couriers, like UPS or FedEx. It was meant to enable patients who are unable to travel, or have difficulty travelling to their local dispensary to get products they can’t find there.
Ahrens is the sponsor of this bill. In the Senate it passed 39-0 and in the House 78-1. It then reached Newsom’s desk.
Newsom stated in his statement of veto that “While I understand the goal to expand patient access to medicinal cannabis, the direct-shipping proposal would be too burdensome to administer and complex.” Newsom said that the Department of Cannabis Control would need to overhaul California’s cannabis tracking-and-trace program, which is going to take a lot of time and money. Moreover, this measure includes numerous restrictions on eligible products – many of which are unclear, overly narrow or unworkable, adding to the implementation challenge.”
According to the fiscal analysis conducted by the Senate Appropriations Committee on the bill, DCC estimated a once-off implementation cost of about $269,000, to modify the Track-and-Trace system. The DCC also reported ongoing costs each year of $472,000. These include the monitoring of shipments, as well as ensuring compliance with the product restriction.
According to California Department of Tax and Fee Administration, this annual cost is less than 0.5% of the taxable cannabis revenue collected by the state last year.
Newsom stated that the administration costs for this program outweighed the benefits it could bring to the patients.
A bill has been introduced that allows any M licensee whose activities include manufacturing, retailing, distributing, or outdoor growing to ship medical cannabis directly to a patient who is a medicinal marijuana patient.
DCC data shows that California has 290 licensed micro-businesses operating under the “adult-use medicinal” and “medicinal license” designations. More than 50 of the licensees have checked vertical integration boxes for manufacturing, retail, distribution and cultivating.
According to DCC, the governor’s veto came at a moment when the medical cannabis market in California is on track to drop below $200 million by 2025. This represents roughly 4% the licensed California marketplace. The DCC estimates that medical cannabis sales will be around $540 million by 2025.
California used to be hailed by many as being the country’s largest medical marijuana market. In fact, a group consisting of around 150 members representing California’s cannabis business, workers, advocates, veterans, and patient organisations estimated the state was making more than $2.5 Billion in medical cannabis sales 10 years earlier.
The group that signed the a The letter In late 2024 you should write to Newsom, and the legislative leaders of your state asking them to grant patient equity to a state which does not exempt its medical cannabis patients from paying 15% excise taxes at retail.
Before you [adult-use] The signers noted that “after legalization millions of Californians had doctor-recommended medical cannabis, which resulted in over $2.5B worth of sales in 2017”. Medical cannabis patients were forced, after legalization due to unaffordable taxes, to purchase their medicines on the unregulated, untested market.
California medical cannabis patients need a prescription from a physician and a Medical Marijuana Identification Card. They can obtain this card through the county health department in their area to avoid paying sales tax. MMICs cost as much as $200, depending on which county you are in.
RELATED: Special report: the decline of medical cannabis in 17 adult-use markets
California voters legalized medical cannabis for the first time in 1996 through Proposition 215. Medical dispensaries, however, were allowed to operate under a grey area of law for the next two decades. California didn’t start regulating commercial operations until the Medicinal and Adult-Use Cannabis Regulation and Safety Act was passed by California lawmakers to consolidate these two industry segments after Prop. The state of California passed Prop.64 in 2016.
DCC says that, despite MAUCRSA being implemented, 57% California cities and counties prohibit cannabis dispensaries. As a result, vast regions are still unserved.
California Legislature to hold its next session in 2022 The law has been passed All counties and cities must allow access to medical marijuana through physical dispensaries The following are some examples of how to use delivery services.
The now vetoed A.B. The 1332 bill was pushed by proponents who argued that some patients are still looking for products their dispensaries and cannabis delivery services don’t have in stock, because the items they want are perishable or not in great demand.
Ahrens, the sponsor of the bill, called it an issue where adult-use drugs are given priority over medical formulations.
“As a result, many patients – particularly those with intractable epilepsy, advanced cancers, multiple sclerosis and neurodegenerative disorders – are struggling to obtain appropriate and effective medical cannabis products,” he said in an author’s comment on the bill. California’s large geography exacerbates the problem, since many patients with serious illnesses live in places where medical cannabis is not readily available. They are also unable to travel to nearby dispensaries to get what they need.
In the early 1990s, as California’s demand for medical cannabis shaped the country, Dr. Laurie Vollen is a board certified physician in clinical prevention medicine. She says that products suited to certain conditions were easier to find and more accessible.
Vollen spoke in April before the California Assembly Business and Professions Committee, urging them to support A.B. Fullen spoke in support of California Assembly Business and Professions Committee Bill 1332 on April 15, telling members that California’s marijuana patients have “become orphans”, and now need to be shipped via couriers.
She said: “It may seem contrary to the current California Legislature but, 29 years after medicinal cannabis was legalized in California medicinal products are virtually non-existent in today’s marijuana marketplace.” Patients who have been using the product for five years cannot get it anymore. There is no dispensary, or delivery service that has the full range of products to serve the diverse needs of cannabis patients. This includes cannabis-naive individuals who are desperate to find alternatives to addictive and dangerous pharmaceuticals.
This legislation was intended to restrict product shipment to only cannabis flowers and tinctures made with non-volatile liquids or mechanical extraction, as well as tinctures such food-oil infusions.
Newsom, in his veto declaration, said that he was open to working together with the lawmakers of California to create strategies for equitable access medical marijuana. Newsom said that this measure “would not achieve” the goal.
The Society for Cannabis Physicians which sponsored the legislation disagrees.
In a letter in support of this bill, the Society wrote: “This bill will ensure that those with serious and complex conditions have access to the medicines they require.” The availability of medicinal cannabis products has decreased since the implementation of Proposition 66 in 2018. This was due to high taxes, regulatory burdens and the preference for adult-use over medical formulations.
Ahrens’s A.B. 1332 included a sunset clause of three years to allow lawmakers the opportunity to review its effectiveness. In an attempt to give lawmakers the opportunity to review its effectiveness, Ahrens included a sunset provision of three years in A.B.
Sponsored Content
This informative article is brought to you by Gen-Europa →
California Gov. Gavin Newsom on October 11 vetoed the bill that aimed at expanding patient access to medicinal cannabis in America’s oldest legally-regulated marketplace.
This legislation is a good example. Assembly Bill 1332Under certain conditions, a licensed microbusiness could ship medical cannabis to California patients directly using common couriers, like UPS or FedEx. This bill was designed to give patients with limited mobility or who have difficulty traveling the opportunity to buy products not available in local dispensaries.
Ahrens is the sponsor of this bill. Last month, 1332 was passed by both chambers of Congress, the Senate and House. The vote totals were 39-0 in favor, while 78-0 for the House.
Newsom’s veto was a statement that said, “While I understand the intention of the author in expanding access for patients to medical marijuana, the proposed program to ship directly to them would be overly complicated and burdensome to administer.” Newsom said that the Department of Cannabis Control would need to overhaul California’s cannabis tracking-and-trace program, which is going to take significant time and money. Moreover, this measure includes numerous restrictions on eligible products – many of which are unclear, overly narrow or unworkable, adding to the implementation challenge.”
According to the fiscal analysis conducted by the Senate Appropriations Committee on the bill, DCC estimated a once-off implementation cost of about $269,000, to modify the Track-and-Trace system. The DCC also reported ongoing costs each year of $472,000. These include the monitoring of shipments, as well as ensuring compliance with the product restriction.
According to California Department of Tax and Fee Administration, this annual cost is less than 0.5% of the taxable cannabis revenue collected by the state last year.
Newsom stated that the administration costs for this program outweigh any possible benefit to the patients.
A bill has been introduced that allows any M licensee whose licensed activity includes retail sale, manufacture, distribution, or outdoor cultivation to ship medical cannabis directly to a patient who is a medicinal marijuana patient.
DCC reports that there are currently 290 microbusinesses in California with licenses for “adult use and medicinal”, or “medicinal”. More than 50 of the licensees have checked vertical integration for manufacturing, distribution, and cultivation.
According to DCC, the governor’s veto came at a moment when the medical cannabis market in California is on track to drop below $200 million by 2025. This represents roughly 4% the licensed California marketplace. In 2021, medical cannabis sales were approximately $540 millions.
California had been hailed for years as having the biggest medical cannabis market. A group of 150 people representing the cannabis industry, the labor movement, veteran and patient groups, estimated that California had medical sales of more than $2 billion less than 10 year ago.
The group that signed the a The letter In late 2024 you should write to Newsom, and the legislative leaders of your state asking for equity on behalf of medical cannabis patients in a State that does not exempt them from 15% excise taxes at retail.
Before you [adult-use] The signers noted that “after legalization millions of Californians had doctor-recommended medical cannabis, which resulted in over $2.5B worth of sales in 2017”. Medical cannabis patients were forced, after legalization due to unaffordable taxes, to purchase their medicines on the unregulated, untested market.
California medical cannabis patients need a prescription from a physician and a Medical Marijuana Identification Card. They can obtain this card through the county health department in their area to avoid paying sales tax. These MMICs may cost up to $200 depending on where you live.
RELATED Special Report: The Decline of Medical Cannabis Markets in 17 Adult Use Markets
California voters legalized medical cannabis for the first time in the U.S. in 1996 through Proposition 215. Medical dispensaries, however, were allowed to operate under a grey area of law for nearly two decades. California didn’t start regulating commercial operations until the Medicinal and Adult-Use Cannabis Regulation and Safety Act was passed by California lawmakers to consolidate these two industry segments after Prop. The state of California passed Prop.64 in 2016.
DCC says that, despite MAUCRSA being implemented, 57% California cities and counties prohibit cannabis dispensaries. As a result, vast regions are still unserved.
California Legislature to hold its next session in 2022 The law has been passed All counties and cities must allow access to medical marijuana through physical dispensaries The following are some examples of how to use delivery services.
But the supporters of A.B. A.B. 1332 was introduced to address the fact that some patients continue to seek out products which are not available in their local cannabis dispensaries because they perish and don’t receive high demand.
Ahrens, who sponsored the bill in its original form, called this a matter of prioritizing products for adult use over formulations intended to treat medicinal conditions.
“As a result, many patients – particularly those with intractable epilepsy, advanced cancers, multiple sclerosis and neurodegenerative disorders – are struggling to obtain appropriate and effective medical cannabis products,” he said in an author’s comment on the bill. California’s large geography exacerbates the problem, since many patients with serious illnesses live in places where medical cannabis is not readily available. They are also unable to travel to nearby dispensaries to get what they need.
In the early 1990s, as California’s demand for medical cannabis shaped the country, Dr. Laurie Vollen is a licensed physician board-certified in clinical prevention medicine. She says that products tailored to certain conditions were easier to find and more accessible.
Vollen spoke in April before the California Assembly Business and Professions Committee, urging them to support A.B. Fullen spoke in support of California Assembly Business and Professions Committee Bill 1332 on April 15, telling members that California’s marijuana patients have “become orphans”, and now need to be shipped via couriers.
She said: “It may seem contrary to the current California Legislature but, 29 years after medicinal cannabis was legalized in California medicinal products are virtually non-existent in today’s marijuana marketplace.” Patients who have been using the product for five years cannot get it anymore. There is no dispensary, or delivery service that has the full range of products to serve the diverse needs of cannabis patients. This includes cannabis-naive individuals who are desperate to find alternatives to addictive and dangerous pharmaceuticals.
It was the intention of this legislation to limit the shipment of cannabis flower, tinctures, and other products to those manufactured using non-volatile chemicals, mechanical extraction, or infusion, like food-oil tinctures, that are made from non-volatile substances.
Newsom, in his veto declaration, said that he was open to working together with the lawmakers of California to create strategies for equitable access medical marijuana. Newsom said that this measure “would not achieve” the goal.
The Society for Cannabis Physicians which sponsored the legislation disagrees.
In a letter in support of this bill, the Society wrote: “This bill will ensure that those with serious and complex conditions have access to the medicines they require.” Since the passage of Proposition 64, the number of available medical cannabis products have decreased significantly. This is due to the high taxes and regulatory requirements that come with the adult-use product.
Ahrens included in A.B. In an attempt to give lawmakers the opportunity to review its effectiveness, Ahrens included a sunset provision of three years in A.B.
Sponsored Content
This informative article is brought to you by Gen-Europa →
Cannabis Law Resources for Poland
Browse essential legal pages on cannabis sales and cultivation in Poland. These guides will help you understand the legal requirements, such as certifications, permits, and compliance.
-
Polish News Registration and Interests of Cannabis Businesses
-
Permissions for Cannabis Sales in Poland
-
Authorization for Importing or Manufacturing Medical Products
-
Permission for Manufacturing or Importing Medical Products
-
Certificate of Good Manufacturing Practices (GMP)
-
Registration of Medical Products in Poland